CDH2 and hepatocellular carcinoma: Because the EMT leads to upregulation of mesenchymal cell markers, we also measured α-SMA, N-cadherin, and Vimentin expression in MCHSs grown with HSCs and HCC cells after CHIR-99021 treatment to precisely characterize the EMT.